Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Tim Townes, PhD
Researcher Professor Emeritus
Department of Biochemistry & Molecular Genetics
The University of Alabama at Birmingham
Shelby Biomedical Research Building
Room 707
1825 University Blvd.
Birmingham, Alabama, United States
Tim M. Townes (b.1951), Professor and Chairman of Biochemistry and Molecular Genetics, received his BS degree in 1973, an M.S. degree in Zoology in 1975, and a Ph.D. degree in Microbiology in 1980 from the University of Tennessee. After completing his graduate studies, he joined Dr. Jerry Lingrel’s group at the University of Cincinnati, where he studied globin gene expression in goats and transgenic mice. He joined the UAB faculty in 1984. His research is supported by grants from NIH.
The major interest of his laboratory is the regulation of gene expression during development. They study the human hemoglobin genes as a model system and translate their understanding of basic mechanisms of globin gene regulation into strategies to correct hemoglobinopathies such as beta-thalassemia and sickle cell disease.
Dr Townes’ work focuses on the following 4 areas:
(1) Globin gene switching during development
(2) Locus Control Region regulation of chromatin structure and gene expression
(3) Genetic modifiers of sickle cell disease severity and
(4) Genetic therapies to correct beta-thalassemia and sickle cell disease.
+myBinderRelated Content
-
Montefiore Medical CenterAt the Division of Hematology at Montefi...
-
Nirmish Shah, MDAs director of Duke’s sickle cell tran...
-
Shengdar Q. Tsai, PhDDr. Shengdar Q. Tsai is an assistant mem...
-
Winthrop-University HospitalNYU Winthrop's pediatric hematologists p...
-
Impact of emergency department care on outcomes of acute pain events in children with sickle cell diseaseThe impact of emergency department (ED) ...
-
Translating sickle cell guidelines into practice for primary care providers with Project ECHOBackground: Approximately 100,000 perso...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
